Cargando…

Exploring the Staphylococcus aureus Gyrase Complex and Human Topoisomerase: Potential Target for Molecular Docking and Biological Studies with Substituted Polychloroaniline

[Image: see text] This paper targets the nuclease activity of polymeric chemical compounds toward bacterial genomic DNA and also elucidates their probable drug-like properties against the enzymes bacterial gyrase complex and human topoisomerase. Poly-o-chloroaniline, poly-m-chloroaniline, and poly-o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomar, Richa, Sarkar, Paratpar, Srivastava, Vivek, Gupta, Pankaj, Malik, Sumira, Khan, Azmat Ali, Tambuwala, Murtaza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688032/ https://www.ncbi.nlm.nih.gov/pubmed/38046322 http://dx.doi.org/10.1021/acsomega.3c05970

Ejemplares similares

Molecular docking and ADMET study of bioactive compounds of Glycyrrhiza glabra against main protease of SARS-CoV2
por: Srivastava, Vivek, et al.
Publicado: (2022)

High-throughput assays for DNA gyrase and other topoisomerases
por: Maxwell, Anthony, et al.
Publicado: (2006)

Activities of gyrase and topoisomerase IV on positively supercoiled DNA
por: Ashley, Rachel E., et al.
Publicado: (2017)

Direct observation of helicase–topoisomerase coupling within reverse gyrase
por: Yang, Xi, et al.
Publicado: (2020)

Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase
por: Roszkowski, Piotr, et al.
Publicado: (2021)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization
por: Hsu, Ya-Han, et al.
Publicado: (2006)

Transcription facilitated genome-wide recruitment of topoisomerase I and DNA gyrase
por: Ahmed, Wareed, et al.
Publicado: (2017)

Dual effectiveness of Alternaria but not Fusarium mycotoxins against human topoisomerase II and bacterial gyrase
por: Jarolim, Katharina, et al.
Publicado: (2016)

What makes a type IIA topoisomerase a gyrase or a Topo IV?
por: Hirsch, Jana, et al.
Publicado: (2021)

Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors
por: Hashem, Heba E., et al.
Publicado: (2020)

Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
por: Dauda, Soziema E., et al.
Publicado: (2023)

The reverse gyrase helicase-like domain is a nucleotide-dependent switch that is attenuated by the topoisomerase domain
por: del Toro Duany, Yoandris, et al.
Publicado: (2008)

Functional Analyses of the Toxoplasma gondii DNA Gyrase Holoenzyme: A Janus Topoisomerase with Supercoiling and Decatenation Abilities
por: Lin, Ting-Yu, et al.
Publicado: (2015)

Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site
por: Franco-Ulloa, Sebastian, et al.
Publicado: (2018)

DNA Gyrase and Topoisomerase IV Mutations and their effect on Quinolones Resistant Proteus mirabilis among UTIs Patients
por: Abdelkreem, Randa H, et al.
Publicado: (2020)

The balance between gyrase and topoisomerase I activities determines levels of supercoiling, nucleoid compaction, and viability in bacteria
por: García-López, Míriam, et al.
Publicado: (2023)

Structural insight into negative DNA supercoiling by DNA gyrase, a bacterial type 2A DNA topoisomerase
por: Papillon, Julie, et al.
Publicado: (2013)

Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI
por: Taylor, James A., et al.
Publicado: (2013)

High Resolution Melting Analysis for Rapid Mutation Screening in Gyrase and Topoisomerase IV Genes in Quinolone-Resistant Salmonella enterica
por: Ngoi, Soo Tein, et al.
Publicado: (2014)

Characterization of Mutations in DNA Gyrase and Topoisomerase IV in Field Strains and In Vitro Selected Quinolone-Resistant Mycoplasma hyorhinis Mutants
por: Li, Jun, et al.
Publicado: (2022)

Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
por: Al-Wahaibi, Lamya H., et al.
Publicado: (2021)

1249. Genetic Evidence That Gepotidacin Shows Well-balanced Dual Targeting against DNA Gyrase And Topoisomerase IV in Neisseria gonorrhoeae
por: Chan, Pan, et al.
Publicado: (2020)

Structure of reverse gyrase with a minimal latch that supports ATP-dependent positive supercoiling without specific interactions with the topoisomerase domain
por: Mhaindarkar, Vaibhav P., et al.
Publicado: (2023)

Comparative Molecular docking analysis of DNA Gyrase subunit A in Pseudomonas aeruginosaPAO1
por: Gupta, Aman, et al.
Publicado: (2013)

A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with Staphylococcus aureus DNA Gyrase
por: Morgan, Harry, et al.
Publicado: (2023)

Reduced Levofloxacin Susceptibility in Clinical Respiratory Isolates of Haemophilus Influenzae Is Not yet Associated with Mutations in the DNA Gyrase and Topoisomerase II Genes in Korea
por: Kim, In-Suk, et al.
Publicado: (2011)

Impact of Amino Acid Substitutions in B Subunit of DNA Gyrase in Mycobacterium leprae on Fluoroquinolone Resistance
por: Yokoyama, Kazumasa, et al.
Publicado: (2012)

Experimental and Molecular Docking Studies of Cyclic Diphenyl Phosphonates as DNA Gyrase Inhibitors for Fluoroquinolone-Resistant Pathogens
por: Saleh, Neveen M., et al.
Publicado: (2022)

Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors
por: Mohammed, Hamada H. H., et al.
Publicado: (2022)

Solvent-Free Synthesis, DNA-Topoisomerase II Activity and Molecular Docking Study of New Asymmetrically N,N'-Substituted Ureas
por: Esteves-Souza, Andressa, et al.
Publicado: (2012)

Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens
por: Sterle, Maša, et al.
Publicado: (2023)

Solution structures of DNA-bound gyrase
por: Baker, Nicole M., et al.
Publicado: (2011)

DNA Gyrase as a Target for Quinolones
por: Spencer, Angela C., et al.
Publicado: (2023)

Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones
por: Malik, Muhammad, et al.
Publicado: (2016)

Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies
por: Mathpal, Deepti, et al.
Publicado: (2021)

Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium
por: Thapa, Jeewan, et al.
Publicado: (2023)

Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine–Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors
por: Mohi El-Deen, Eman M., et al.
Publicado: (2019)

Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase Inhibitors
por: Yuan, Jie, et al.
Publicado: (2010)

Inhibition of translesion DNA polymerase by archaeal reverse gyrase
por: Valenti, Anna, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_46squp85937dripfqbearhrnlv